Skip to main content
Clinical Trials/NL-OMON40192
NL-OMON40192WithdrawnNot Applicable

Chromosomal instability as indicator for the treatment of progressive mucosal lesions of the oral cavity: a prospective study. - Treatment of mucosal lesions of the oral cavity using a cancerrisk-test

Medisch Universitair Ziekenhuis Maastricht0 sites374 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Enrollment
374

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Subject has a minimal age of 18 years
  • premalignant laesion of the oropharynx, classified as hyperkeratosis, hyperplasia, mild or moderate dysplasia
  • Singned informed consent form

Exclusion Criteria

  • Prior malignancy or laesion classified as severe dysplasia or carcinoma in situ at the same anatomical location of the oropharynx.
  • Prior treatment of laesions at the same anatomical location of the oropharynx (ie radiotherapy)
  • Insufficient biopsy material to perform a FISH analysis.
  • Pregnancy, based on physical load (ie extra anesthaesia)

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Similar Trials